Mayo, T.; Armstrong, A.; Kircik, L.; Silverberg, J.; Blauvelt, A.; Esdaile, B.; Schneider, S.; Mark, T.; Gooderham, M.; Alexis, A. Efficacy and Safety of up to Two Years of Tralokinumab Treatment in Adults of Different Racial Subgroups With Moderate-to-Severe Atopic Dermatitis. J of Skin 2023, 7, s144.